BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olson AL, Brown KK, Fischer A. Connective Tissue Disease–Associated Lung Disease. Immunology and Allergy Clinics of North America 2012;32:513-36. [DOI: 10.1016/j.iac.2012.09.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Ruano CA, Lucas RN, Leal CI, Lourenço J, Pinheiro S, Fernandes O, Figueiredo L. Thoracic Manifestations of Connective Tissue Diseases. Current Problems in Diagnostic Radiology 2015;44:47-59. [DOI: 10.1067/j.cpradiol.2014.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
2 Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. QJM 2019;112:81-93. [PMID: 30605544 DOI: 10.1093/qjmed/hcy272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Oguz EO, Kucuksahin O, Turgay M, Yildizgoren MT, Ates A, Demir N, Kumbasar OO, Kinikli G, Duzgun N. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study. Clin Rheumatol 2016;35:663-6. [PMID: 26758437 DOI: 10.1007/s10067-015-3167-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
4 Spagnolo P, Cordier JF, Cottin V. Connective tissue diseases, multimorbidity and the ageing lung. Eur Respir J 2016;47:1535-58. [PMID: 26917611 DOI: 10.1183/13993003.00829-2015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
5 Oliveira RP, Ribeiro R, Melo L, Grima B, Oliveira S, Alves JD. Connective tissue disease-associated interstitial lung disease. Pulmonology 2020:S2531-0437(20)30004-0. [PMID: 32044296 DOI: 10.1016/j.pulmoe.2020.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Walsh SLF, Devaraj A, Enghelmayer JI, Kishi K, Silva RS, Patel N, Rossman MD, Valenzuela C, Vancheri C. Role of imaging in progressive-fibrosing interstitial lung diseases. Eur Respir Rev 2018;27:180073. [PMID: 30578332 DOI: 10.1183/16000617.0073-2018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
7 Suzuki A, Kondoh Y, Swigris JJ, Ando M, Kimura T, Kataoka K, Yamano Y, Furukawa T, Numata M, Sakamoto K, Hasegawa Y. Performance of the St George’s Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease: SGRQ in CTD-ILD. Respirology 2018;23:851-9. [DOI: 10.1111/resp.13293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Suzuki A, Kondoh Y, Fischer A. Recent advances in connective tissue disease related interstitial lung disease. Expert Rev Respir Med 2017;11:591-603. [PMID: 28544856 DOI: 10.1080/17476348.2017.1335600] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
9 Wilson TM, Solomon JJ, Demoruelle MK. Treatment approach to connective tissue disease-associated interstitial lung disease. Curr Opin Pharmacol 2022;65:102245. [PMID: 35662004 DOI: 10.1016/j.coph.2022.102245] [Reference Citation Analysis]
10 Ryan PH, Rice CH, Lockey JE, Black B, Burkle J, Hilbert TJ, Levin L, Brokamp C, Mckay R, Wolfe C, Lemasters GK. Childhood exposure to Libby amphibole asbestos and respiratory health in young adults. Environmental Research 2017;158:470-9. [DOI: 10.1016/j.envres.2017.07.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
11 Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V. The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease. Arthritis Rheumatol 2018;70:1544-54. [DOI: 10.1002/art.40574] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 19.3] [Reference Citation Analysis]
12 Campo I, Zorzetto M, Bonella F. Facts and promises on lung biomarkers in interstitial lung diseases. Expert Review of Respiratory Medicine 2015;9:437-57. [DOI: 10.1586/17476348.2015.1062367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
13 Geerts S, Wuyts W, Langhe E, Lenaerts J, Yserbyt J. Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists. Sarcoidosis Vasc Diffuse Lung Dis 2017;34:326-35. [PMID: 32476865 DOI: 10.36141/svdld.v34i4.5894] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Kusmirek JE, Kanne JP. Thoracic Manifestations of Connective Tissue Diseases. Seminars in Ultrasound, CT and MRI 2019;40:239-54. [DOI: 10.1053/j.sult.2018.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'dwyer DN, Donnelly SC. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease–Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol 2019;71:182-95. [DOI: 10.1002/art.40769] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
16 Bonella F, Caramaschi P. The Ambitious Goal of Validating Prognostic Biomarkers for Systemic Sclerosis-related Interstitial Lung Disease. J Rheumatol 2013;40:1034-6. [DOI: 10.3899/jrheum.130549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
17 Migita K, Arai T, Jiuchi Y, Izumi Y, Iwanaga N, Kawahara C, Suematsu E, Miyamura T, Tsutani H, Kawabe Y, Matsumura R, Mori S, Ohshima S, Yoshizawa S, Suenaga Y, Ogushi F, Kawabata M, Furukawa H, Matsui T, Bito S, Tohma S. Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study. Medicine (Baltimore) 2014;93:e175. [PMID: 25474431 DOI: 10.1097/MD.0000000000000175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
18 Olson AL, Gifford AH, Inase N, Fernández Pérez ER, Suda T. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype. Eur Respir Rev 2018;27:180077. [DOI: 10.1183/16000617.0077-2018] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
19 Suzuki A, Kondoh Y, Swigris JJ, Matsuda T, Kimura T, Kataoka K, Ando M, Hashimoto N, Sakamoto K, Hasegawa Y. Performance of the COPD Assessment Test in patients with connective tissue disease-associated interstitial lung disease. Respiratory Medicine 2019;150:15-20. [DOI: 10.1016/j.rmed.2019.01.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Lu H, Ji X, Liang S, Fan L, Bai J, Chen K, Zhou Y, Li H, Xu J. Pathogen characteristics reveal novel antibacterial approaches for interstitial lung disease. Pulmonary Pharmacology & Therapeutics 2014;29:250-4. [DOI: 10.1016/j.pupt.2014.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Martinović Kaliterna D, Petrić M. Biomarkers of skin and lung fibrosis in systemic sclerosis. Expert Review of Clinical Immunology 2019;15:1215-23. [DOI: 10.1080/1744666x.2020.1670062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
22 Mira-Avendano IC, Abril A. Pulmonary manifestations of Sjögren syndrome, systemic lupus erythematosus, and mixed connective tissue disease. Rheum Dis Clin North Am 2015;41:263-77. [PMID: 25836642 DOI: 10.1016/j.rdc.2015.01.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
23 Ahuja J, Arora D, Kanne JP, Henry TS, Godwin JD. Imaging of Pulmonary Manifestations of Connective Tissue Diseases. Radiologic Clinics of North America 2016;54:1015-31. [DOI: 10.1016/j.rcl.2016.05.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]